Comparative prognosis analysis of ovarian squamous cell carcinoma versus serous carcinoma: Insights from the SEER database
International Journal of Gynecology & Obstetrics · 2025-02 · 168 (2) · 559-571
DOI: 10.1002/ijgo.15899 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 11.09.2024. Verfasst von Xianglin Nie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Carcinoma, Squamous Cell, Cystadenocarcinoma, Serous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Nature Science Foundation for young scientist in Jiangsu Province, Jiangsu Province Traditional Chinese Medicine Science and Technology Development Plan Project-Key Project.
Abstract (Originalsprache)
Objective
The aim of this study was to identify survival rates and potential prognostic factors of ovarian squamous cell carcinoma (OSCC), offering valuable insights for clinical decision making.
Methods
Leveraging the Surveillance, Epidemiology, and End Results (SEER) database, we selected 11 078 serous carcinoma (SC) patients and 198 OSCC patients based on predetermined criteria diagnosed from 2000 to 2020. We compared the overall survival (OS) and cancer‐specific survival (CSS) before and after propensity score matching (PSM) in two groups. Prognostic differences were also compared between OSCC and SC groups at different stages. Univariate and multivariate Cox regression analyses were performed to investigate the impact of clinical and pathologic variables on the survival of patients with OSCC. Finally, we developed and validated a nomogram predictive model.
Results
OSCC tumors exhibited distinct characteristics, being relatively larger, more frequently unilateral, and better differentiated than SC tumors. After PSM, Kaplan–Meier analysis revealed significantly lower survival rates for OSCC patients in Stages IIB–IV, while Stages IA–IC displayed comparable survival. Independent risk factors for OSCC patients included advanced age, single marital status, higher tumor stage, and increased tumor size. Conversely, higher median household income and chemotherapy emerged as independent protective factors. Our predictive model and nomogram accurately forecasted patient survival rates in both SEER and internal validation datasets.
Conclusion
OSCC patients face significantly poorer prognosis than their SC counterparts, except in the very early stages. Higher median household income was associated with better OSCC survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
ORCID-Profile: Xianglin Nie, Wenjun Cheng
Förderung
- National Natural Science Foundation of China
- National Nature Science Foundation for young scientist in Jiangsu Province
- Jiangsu Province Traditional Chinese Medicine Science and Technology Development Plan Project-Key Project
- General Project of Yili Clinical Medical Research Institute
- Jiangsu Provincial Maternal and Child Health Research Fund
Zitieren
APA
Nie, X., Xu, T., & Cheng, W. (2025). Comparative prognosis analysis of ovarian squamous cell carcinoma versus serous carcinoma: Insights from the SEER database. International Journal of Gynecology & Obstetrics, 168(2), 559-571. https://doi.org/10.1002/ijgo.15899
Vancouver
Nie X, Xu T, Cheng W. Comparative prognosis analysis of ovarian squamous cell carcinoma versus serous carcinoma: Insights from the SEER database. International Journal of Gynecology & Obstetrics. 2025;168(2):559-571. doi:10.1002/ijgo.15899
BibTeX
@article{Nie2025,
author = {Nie, Xianglin and Xu, Ting and Cheng, Wenjun},
title = {Comparative prognosis analysis of ovarian squamous cell carcinoma versus serous carcinoma: Insights from the SEER database},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
volume = {168},
number = {2},
pages = {559--571},
doi = {10.1002/ijgo.15899}
}
EUVIMED